Fig. 2
From: Identification of TRPM2 as a prognostic factor correlated with immune infiltration in ovarian cancer
The prognostic feature of TRPM2 expression in ovarian cancer according to DriverDBv3 and PrognoScan. (A-D) Association between TRPM2 expression and OS (A), 5-years OS (B), DSS (C), and 5-years DSS (D) in ovarian cancer based on DriverDBv3. (E) Association between TRPM2 expression and OS in ovarian cancer in PrognoScan. (p < 0.05 was considered significant. n: TRPM2-high = 186,TRPM2-low = 186) (F) Immunohistochemistry result of TRPM2 expression in ovarian cancer tissuse (Tumor) and normal tissue (Normal) according to The Human Protein Atla. (G-H) Immunohistochemistry result of TRPM2 expression (G) and average optical density (AOD) analysis of clinical ovarian cancer tissue samples (Tumor) and normal tissue sample (Normal). N = 5, Student’s t-test, ***p < 0.001. (Scale bar = 400 μm, n = 5)